A biomimetic nanosystem can deliver therapeutic proteins to selectively target cancerous tumors, according to a team of Penn State researchers.
Using a protein toxin called gelonin from a plant found in the Himalayan mountains, the researchers caged the proteins in self-assembled metal-organic framework (MOF) nanoparticles to protect them from the body’s immune system. To enhance the longevity of the drug in the bloodstream and to selectively target the tumor, the team cloaked the MOF in a coating made from cells from the tumor itself.
Blood is a hostile environment for drug delivery. The body’s immune system attacks alien molecules or else flushes them out of the body through the spleen or liver. But cells, including cancer cells, release small particles called extracellular vesicles that communicate with other cells in the body and send a “don’t eat me” signal to the immune system.
“We designed a strategy to take advantage of the extracellular vesicles derived from tumor cells,” said Siyang Zheng, associate professor of biomedical and electrical engineering at Penn State. “We remove 99 percent of the contents of these extracellular vesicles and then use the membrane to wrap our metal-organic framework nanoparticles. If we can get our extracellular vesicles from the patient, through biopsy or surgery, then the nanoparticles will seek out the tumor through a process called homotypic targeting.”
Gong Cheng, lead author on a new paper describing the team’s work and a former postdoctoral scholar in Zheng’s group now at Harvard, said, “MOF is a class of crystalline materials assembled by metal nodes and organic linkers. In our design, self-assembly of MOF nanoparticles and encapsulation of proteins are achieved simultaneously through a one-pot approach in aqueous environment. The enriched metal affinity sites on MOF surfaces act like the buttonhook, so the extracellular vesicle membrane can be easily buckled on the MOF nanoparticles. Our biomimetic strategy makes the synthetic nanoparticles look like extracellular vesicles, but they have the desired cargo inside.”
The nanoparticle system circulates in the bloodstream until it finds the tumor and locks on to the cell membrane. The cancer cell ingests the nanoparticle in a process called endocytosis. Once inside the cell, the higher acidity of the cancer cell’s intracellular transport vesicles causes the metal-organic framework nanoparticles to break apart and release the toxic protein into cytosol and kill the cell.
“Our metal-organic framework has very high loading capacity, so we don’t need to use a lot of the particles and that keeps the general toxicity low,” Zheng said.
The researchers studied the effectiveness of the nanosystem and its toxicity in a small animal model and reported their findings in a cover article in the Journal of the American Chemical Society.
The researchers believe their nanosystem provides a tool for the targeted delivery of other proteins that require cloaking from the immune system. Penn State has applied for patent protection for the technology.
Learn more: Camouflaged nanoparticles used to deliver killer protein to cancer
The Latest on: Biomimetic nanosystem
[google_news title=”” keyword=”biomimetic nanosystem” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Biomimetic nanosystem
- Biomimetic Materials Market Upcoming Trends, Size, Key Players, Revenue, Share, and Forecast 2024 to 2032on April 16, 2024 at 9:40 pm
Report Ocean recently published a research report titled “Biomimetic Materials Market” 2024 Forecast to 2032 Analysis by Market Trends.” This study delivers accurate economic projections, worldwide ...
- China realizes monitoring of coral reefs growth in South China Sea using bionic submersibleon April 15, 2024 at 6:19 pm
They developed a biomimetic soft-bodied submersible shaped like a manta ray. The team has been researching the bionic submersible since 2016, breaking through key technologies such as bionic fluid ...
- First Study Using Biomimetic AI Digital Twins and Multiomics in Genetics Researchon April 8, 2024 at 5:00 pm
Revolutionary genomic research by Genzeva, LumaGene, RYLTI, Brigham & Women’s Hospital of Harvard University, and QIAGEN Digital Insights applied an innovative use of multiomics and biomimetic digital ...
- New ways to strengthen biomimetic spider-silkon March 4, 2024 at 12:01 pm
By using the same secret the researchers are able to create biomimetic spider-silk fibers in a non-toxic way. The study is published in Advanced Functional Materials. Spider silk is known for ...
- Biomimetic Building Facades To Reduce HVAC Loadson April 28, 2023 at 7:34 pm
Buildings currently consume about 50% of the world’s electricity, so finding ways to reduce the loads they place on the grid can save money and reduce carbon emissions. Scientists at the ...
- Biomimetic Connections, LLCon July 30, 2019 at 6:09 am
Advancing the application of biomimetics to engineering. Provides optical engineering corporations and their researchers with access to biological design paradigms(tm) and university 'bio-inspired'IP ...
- Flipkart Founders Bets On Med-Tech Startup Wrig Nanosystem; Invests $2.3 Mnon July 28, 2015 at 5:00 pm
New Delhi-based medical technology startup, Wrig Nanosystems has raised $2.3 Mn (about INR15 Cr.) from Flipkart Cofounders Sachin and Binny Bansal; Ranbaxy & Fortis promoters Malvinder and ...
via Bing News